To examine the effects of ITPP on tumor-associated angiogenesis, five prominent circulatory pro-angiogenic factors (VEGFA, ANG1/2, EGF, PECAM1/CD31) were assessed during ITPP monotherapy. Here, PECAM1 is linked to neoplasm.